{"id":"W3007541271","doi":"10.1016/j.ejca.2020.01.007","title":"European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention","year":2020,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Instituto Superior de Agronomia; Merck Sharp and Dohme; Sandoz; Bristol-Myers Squibb Canada; Genentech; Sun Pharma; Genesis Pharma; Eisai; SkylineDx; Pfizer; Biogen; Incyte; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Mylan; Galderma; UCB; AbbVie; Health Research; Novartis; Celgene; LEO Pharma; Bayer; Wyeth; Agence Nationale de la Recherche; Roche; Sanofi; Merck; Amgen; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Guideline; Epidemiology; Medicine; Basal cell; Dermatology; Oncology; Pathology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005471534,0.001687986,0.002705836,0.004554842,0.0006633805,0.001457268,0.00423453,0.005183756,0.003745565],"category_scores_gemma":[0.01110997,0.0008012441,0.004000814,0.004490782,0.0009118671,0.001040269,0.001685403,0.004070074,0.003558204],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002691185,"about_ca_system_score_gemma":0.006880483,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02426867,"about_ca_topic_score_gemma":0.03621773,"domain_scores_codex":[0.9919006,0.002692561,0.002187524,0.0003323409,0.002503633,0.000383443],"domain_scores_gemma":[0.9885991,0.003431966,0.00152068,0.0003164475,0.005591828,0.0005400406],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000133772,0.0001880016,0.00274387,0.01071721,0.0003333876,0.0003681999,0.0001563277,0.001370452,0.001285559,0.00329363,0.8280917,0.1513178],"study_design_scores_gemma":[0.0002915128,0.0001549096,0.02244648,0.03357863,0.0008730379,0.002163523,0.0002238378,0.0008313435,0.0009465481,0.004970126,0.9334314,0.00008864408],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"methods","genre_scores_codex":[0.004634919,0.7349229,0.02314077,0.08918404,0.02175594,0.003716442,0.05323961,0.001270784,0.06813464],"genre_scores_gemma":[0.04438043,0.5633653,0.08519864,0.09778485,0.007478613,0.009643369,0.1359462,0.0006465383,0.05555609],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.02426867,"threshold_uncertainty_score":0.04825485,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0533766450898083,"score_gpt":0.3284284051082279,"score_spread":0.2750517600184196,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}